Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
| Image |  |
|---|---|
| Description | scientific article published in January 2001 |
| Author/s |
author: Matthieu Garnier Eva-Maria Mandelkow Doris Marko Paul Greengard |
| Publication date | January 1, 2001 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |